List of publications

All the publications of the C3M teams.

Export in CSV
Atherosclerosis Calcification: Focus on Lipoproteins.

Authors Neels JG, Leftheriotis G, Chinetti G

Metabolites Mar 2023

Critical Overview on Endocrine Disruptors in Diabetes Mellitus.

Authors Hinault C, Caroli-Bosc P, Bost F, Chevalier N

International journal of molecular sciences Mar 2023

Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors.

Authors Pastor S, Wicinski J, Charafe-Jauffret E, Verhoeyen E, Guittard G, Ginestier C

STAR protocols Feb 2023

Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.

Authors Cano A, Vazquez-Chantada M, Conde-Vancells J, Gonzalez-Lahera A, Mosen-Ansorena D, Blanco FJ, Clément K, Aron-Wisnewsky J, Tran A, Gual P, García-Monzón C, Caballería J, Castro A, Martínez-Chantar ML, Mato JM, Zhu H, Finnell RH, Aransay AM

Biomedicines Feb 2023

Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues.

Authors Solier S, Mondini M, Meziani L, Jacquel A, Lacout C, Berghe TV, Julé Y, Martinou JC, Pierron G, Rivière J, Deloger M, Dupuy C, Slama-Schwok A, Droin N, Vandenabeele P, Auberger P, Deutsch E, El-Benna J, Dang PM, Solary E

International journal of molecular sciences Feb 2023

[Medulloblastoma: The latest major advances].

Authors Contenti J, Bost F, Mazure NM

Bulletin du cancer Feb 2023

Spatial patterns of the cap-binding complex eIF4F in human melanoma cells.

Authors Tang X, Pu Y, Peng H, Li K, Faouzi S, Lu T, Pu D, Cerezo M, Xu J, Li L, Robert C, Shen S

Computational and structural biotechnology journal Feb 2023

From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis.

Authors Troadec MB, Porteu F, Arcangeli ML, Foudi A, Bluteau D, De Sepulveda P, Guillouf C, Mazure NM, Meggetto F, Brunet De La Grange P, Broccardo C

Bulletin du cancer Feb 2023

Novel Therapeutic Targets in Melanoma.

Authors Cerezo M, Rocchi S

Cancers Feb 2023

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Authors Muselli F, Mourgues L, Rochet N, Nebout M, Guerci A, Verhoeyen E, Krug A, Legros L, Peyron JF, Mary D

Cancers Feb 2023